Exscientia

Exscientia

Biotechnology, The Schrödinger Building Oxford Science Park, Oxford, Oxfordshire, OX4 4GE, United Kingdom, 201-500 Employees

exscientia.ai

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 44***********

Who is EXSCIENTIA

Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage o...

Read More

map
  • The Schrödinger Building Oxford Science Park, Oxford, Oxfordshire, OX4 4GE, United Kingdom Headquarters: The Schrödinger Building Oxford Science Park, Oxford, Oxfordshire, OX4 4GE, United Kingdom
  • 2012 Date Founded: 2012
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from EXSCIENTIA

Exscientia Org Chart and Mapping

Employees

Molly McDonald

Executive Director, People

Aayush Gupta

AI Research Scientist (Computational Chemistry)

Maria Dominguez

VP, Head of Pre-Clinical

Daniel Seeliger

Executive Director Computational Drug Design

Shannon Dudley

Senior People and Operations Specialist

Mason Burlage

Cheminformatics Research Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Exscientia

Answer: Exscientia's headquarters are located at The Schrödinger Building Oxford Science Park, Oxford, Oxfordshire, OX4 4GE, United Kingdom,

Answer: Exscientia's phone number is 44***********

Answer: Exscientia's official website is https://exscientia.ai

Answer: Exscientia's revenue is $10 Million to $25 Million

Answer: Exscientia has 201-500 employees

Answer: Exscientia is in Biotechnology

Answer: Exscientia contact info: Phone number: 44*********** Website: https://exscientia.ai

Answer: Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. Weve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a drug candidate compared with industry standards. By actively applying AI to precision engineer medicines more rapidly and efficiently, we allow the best ideas of science to rapidly become the best medicines for patients.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access